January 17, 2025

The Winter 2025 advocacy blog Considering Clinical Trials is now available

January 10, 2025

Adjuvant tamoxifen reduces 15-year risk of recurrence in ‘good risk’ DCIS without radiation therapy (mentions E5194)

December 12, 2024

Press Release: Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation

December 10, 2024

Press Release: Autologous stem cell transplants do not improve survival for mantle cell lymphoma patients with undetectable MRD, clinical trial shows

December 4, 2024

Upfront treatment and early intervention to get attention at ASH 2024, including mantle cell lymphoma with the striking results of study EA4151

November 26, 2024

WATCH: David Schiff discusses the striking survival improvement for patients with low-grade brain tumors found in study E3F05

November 25, 2024

Press Release: ECOG-ACRIN adds a late-breaking abstract to its ASH 2024 presentation line-up

October 30, 2024

WATCH: Behind the ECOG-ACRIN E1910 trial with lead investigator Dr. Mark Litzow

October 15, 2024

Cooperative groups develop consensus nomenclature for radiation targets on future lymphoma clinical trials

ECOG-ACRIN Cancer Research Group